Access to Information Requests Completed - August 2011

This content was archived on June 24, 2013.

The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)

If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.

Completed Requests

For the month of August 2011

Request #	Summary of Requests	Status of Completed Request	Number of Pages Disclosed
A-2009-01186	Information regarding the product Adderall XR by Shire Biochem Inc.	Disclosed in part	751
A-2009-01430	Information regarding the product Zambroza, NPN 80008539 by Nature's Sunshine Products of Canada Ltd.	Disclosed in part	1,097
A-2010-00700	All documents relating to communication between the Society of Obstetricians and Gynaecologists of Canada (SOGC) and Health Canada regarding Guideline 'Clinical Development of Steroidal Contraceptives Used by Women'.	Disclosed in part	37
A-2010-00738	Any documents to show the total costs of the program to renew the warning labels on cigarette packages. (Jan 1, 2003 to Oct 6, 2010).	Disclosed in part	99
A-2010-00852	Information regarding the product Herstat 3% propolis, NPN 80021252 by Hela Canada Ltd.	Disclosed in part	308
A-2010-01044	All information on the tobacco warning labels renewal project / going from being suspended to being pursued. (Sep 1, 2010 to Jan 10, 2011).	Disclosed in part	180
A-2010-01050	All tobacco-related records related to the January and September 2010 Provincial, Territorial and Federal Health Ministers' meetings.	Disclosed in part	113
A-2010-01051	All documents related to various meetings with Imperial Tobacco, Japan International Tobacco and Rothman's Benson and Hedges, Non-Smokers Right's Association, Canadian Cancer Society and University of Waterloo.	Disclosed in part	375
A-2010-01075	All documentation related to funding, contribution agreements or grants provided by Health Canada in support of the 6th National Conference on Tobacco or Health that took place November 1 - 4, 2009, in Montreal, Quebec.	Disclosed in part	254
A-2010-01095	All briefing notes prepared for the Minister of Health or her staff on the subject of tobacco/cigarette labelling. (Aug 1, 2010 to Jan 19, 2011).	All excluded	0
A-2010-01096	Copies of the results from testing performed in 2010 or late 2009 on private wells in four First Nations communities. And a copy of the guidelines provided and any communications to homeowners as a result of the test results. (Jan 1, 2009 to Jan 1, 2011).	Disclosed in part	788
A-2010-01214	Various information on Information Management & Records Management. (Jan 1, 2009 to Jan 1, 2011).	All disclosed	935
A-2010-01239	Information regarding the Report submitted by the Natural Health Products Advisory Committee to the Natural Health Products Program.	All disclosed	769
A-2010-01261	All emails written by Meena Ballantyne about energy drinks. (Sep 1, 2010 to Jan 31, 2011).	Disclosed in part	44
A-2010-01270	Documents of procedures and policies used by professional staff (evaluators) within the site licensing assessment division in the conduct of their duties in evaluating site license submissions.	Disclosed in part	1,624
A-2010-01276	Information regarding the product Genacol, NPN 80022455 by Corporation Genacol Canada Inc.	Disclosed in part	193
A-2010-01277	Information regarding the product Genacol Plus, NPN 80022836 by Corporation Genacol Canada Inc.	Disclosed in part	74
A-2010-01278	Information regarding the product Genacol C Plus, NPN 80023547 by Corporation Genacol Canada Inc.	Disclosed in part	56
A-2010-01412	All documents in 'Biotechnology 2' section about AquAdvantage salmon by AquaBounty Technologies. (Jan 1, 2010 to Aug 31, 2010).	Disclosed in part	82
A-2010-01422	Information regarding the product Strattera by Eli Lilly Canada Inc.	Disclosed in part	379
A-2010-01514	All communications from the Privy Council Office, the Office of the Prime Minister and the Treasury Board pertaining to the use of the term 'Harper Government' in public communications. (Sep 1, 2010 to Mar 22, 2011).	Disclosed in part	246
A-2011-00014	A copy of the narcotics and Controlled Substances License issued to Sorinco Inc.	Disclosed in part	2
A-2011-00102	All documents regarding the Industry-Government Food Processing Action Plan. (Jan 1, 2011 to Apr 1, 2011).	Disclosed in part	130
A-2011-00122	Copy of the initial request, as well as the requests for the updating of the product Cold medication extra strength N tab, DIN 01957627.	No records exist	0
A-2011-00123	Copy of the initial request, as well as the requests for the updating of the product Cold medication extra strength D tab, DIN 01957619.	No records exist	0
A-2011-00131	Information regarding the product Sacox, DIN 02230508 by Huvepharma AD.	Disclosed in part	80
A-2011-00198	All documents regarding Tessalon or Benzonatate containing products.	Disclosed in part	5
A-2011-00238	All emails to and from Christina Zehaluk regarding discretionary food fortification. (Jan 1, 2011 to May 17, 2011).	Disclosed in part	85
A-2011-00240	All emails to and from Christina Zehaluk regarding discretionary food fortification. (Jul 1, 2010 to Dec 31, 2010).	Disclosed in part	56
A-2011-00253	Information regarding the product Master Formulae-Pau D'Arco, NPN 80010854.	Disclosed in part	10
A-2011-00260	Information regarding the patent hold for the product co-pantoprazole 20mg 40mg tablets.	Disclosed in part	2
A-2011-00262	Information regarding the patent hold for product gen-pantoprazole 20mg 40mg tablets.	Disclosed in part	2
A-2011-00263	Information regarding the patent hold for product ratio-pantoprazole 20mg 40mg tablets.	Disclosed in part	2
A-2011-00290	A copy of all Site Licence certificates currently active with the Natural Health Products Directorate.	All disclosed	27
A-2011-00303	House book notes and house briefing notes developed for the Minister, Parliamentary Secretary and/or Deputy Minister for Question Period and/or appearances before Parliamentary Committees. (May 1, 2010 to Jun 6, 2011).	Disclosed in part	20
A-2011-00307	Correspondence between the governments of Canada and Australia relating to plain packaging. (Jan 1, 1998 to Jun 6, 2011).	Disclosed in part	9
A-2011-00319	AERs for the product Benylin. Report numbers: 000011132, 00018033, 000023467, 000031564, 000033740, 000037747, 000038164, 000067019, 000070432 and 000090514.	Disclosed in part	92
A-2011-00357	5 reference letters in support of the Non-Smokers Rights Association.	All disclosed	5
A-2011-00360	Information regarding the number of educational leave requests made by Health Canada employees. (June 29, 2006 to Jun 30, 2011).	All disclosed	1
A-2011-00367	AERs for the product Yaz. Report numbers: 000364028, 000364040, 000364932 and 000365190.	Disclosed in part	4
A-2011-00368	AERs for the product Yasmin. Report numbers: 000363316, 000363436, 000365014, 000365185, 000365187 and 000365191.	Disclosed in part	8
A-2011-00369	AERs for the product Xarelto. Report numbers: 000363320 and 000364011.	Disclosed in part	3
A-2011-00370	AER for the product Levitra. Report number: 000363208.	Disclosed in part	2
A-2011-00371	AER for the product Diane 35. Report number: 000365189.	Disclosed in part	1
A-2011-00372	AERs for the product Cipro. Report numbers: 000364731, 000365274 and 000365366.	Disclosed in part	3
A-2011-00373	AERs for the product Avelox. Report numbers: 000363437, 000363562, 000363767, 000363913, 000364348, 000364620, 000364720, 000365093, 000365102 and 000365315.	Disclosed in part	10
A-2011-00374	Information regarding the number of educational leave requests to study law made by Health Canada employees. (Jun 29, 2006 to Jun 30, 2011).	No records exist	0
A-2011-00379	AERs for the product DAXAS (roflumilast). Report numbers: 000363569 and 000364926.	Disclosed in part	2
A-2011-00391	Document indicating how much money your department paid to various companies in the form of late fees (for payments).	All disclosed	89
A-2011-00392	Rating guide (instructions for evaluation) for questions pertaining to the preparation of briefing notes for process # 11-NHW-NX-IA-008 and process # 10-NHW-CS-IA-003.	Disclosed in part	6
A-2011-00394	All briefing notes and memos to the Health Minister. (May 2, 2011 to Jun 29, 2011).	All disclosed	4
A-2011-00396	AERs for the product Yaz. Report numbers: 000361126, 000361635, 000361797 and 000362325.	Disclosed in part	4
A-2011-00397	AER for the product Yasmin. Report number: 000362339.	Disclosed in part	1
A-2011-00398	AERs for the product Xarelto. Report numbers: 000361710 and 000361994.	Disclosed in part	3
A-2011-00399	AERs for the product Mirena. Report numbers: 000362314 and 000362712.	Disclosed in part	2
A-2011-00400	AERs for the product Gadovist. Report numbers: 000362227, 000362324 and 000362430.	Disclosed in part	3
A-2011-00401	AER for the product Cipro XL. Report number: 000361235.	Disclosed in part	2
A-2011-00402	AER for the product Betaseron. Report number: 000361310.	Disclosed in part	2
A-2011-00403	AERs for the product Avelox. Report numbers: 000361634, 000361734, 000362726, 000362762, 000362940 and 000362947.	Disclosed in part	7
A-2011-00404	Previously disclosed Access to Information requests relating to the inappropriate computer and internet usage by government employees. File numbers: A-2009-00225, A-2009-00226, A-2009-00227, A-2009-00228 and A-2010-01034.	Disclosed in part	665
A-2011-00408	Request the documents that are in the following number: MECS#11-102411-633.	All disclosed	160
A-2011-00412	Request the documents that are in the following number:MECS#10-127491-168.	All disclosed	6
A-2011-00414	AERs for the product Yaz. Report numbers: 000358994, 000360288, 000360300, 000360412 and 000360821.	Disclosed in part	5
A-2011-00415	AERs for the product Yasmin. Report numbers: 000359752, 000360291 and 000360420.	Disclosed in part	6
A-2011-00416	AERs for the product Xarelto. Report numbers: 000359367 and 000360068.	Disclosed in part	4
A-2011-00417	AER for the product Triquilar. Report number: 000360429.	Disclosed in part	1
A-2011-00418	AERs for the product Mirena. Report numbers: 000359188, 000359749, 000359975 and 000359986.	Disclosed in part	5
A-2011-00419	AER for the product Magnevist. Report number: 000359459.	Disclosed in part	1
A-2011-00420	AERs for the product Gadovist. Report numbers: 000359361 and 000360246.	Disclosed in part	3
A-2011-00421	AER for the product Cipro. Report number: 000359763.	Disclosed in part	1
A-2011-00422	AERs for the product Avelox. Report numbers: 000359299, 000359331, 000359510, 000359594, 000359598, 000359783, 000359860, 000359866 and 000360236.	Disclosed in part	10
A-2011-00424	All callups processed by this institution in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of May 2011.	Disclosed in part	42
A-2011-00426	Documentation which indicates all appointments term and casual employees by this institution in the National Capital Region under the term of the Public Service Employment Act during May 2011.	All disclosed	1
A-2011-00427	All local purchase orders processed by this institution in the National Capital Region for the procurement of Temporary Help Services during the period of May 2011.	Disclosed in part	3
A-2011-00433	All documents pertaining to the importation or utilisation of controlled opioid narcotics, analgesics, or anaesthetics for humanitarian use in Haiti following the January 2010 earthquake. Documents for the period of January-March 2010	Disclosed in part	16
A-2011-00436	A listing of the Access to Information requests submitted to Health Canada. (Jan 1, 1990 to Dec 31, 1990).	Disclosed in part	20
A-2011-00438	A listing of the Access to Information requests submitted to Health Canada for the period of June 2011.	All disclosed	9
A-2011-00439	A listing of the Access to Information requests submitted to Health Canada. (Jan 1, 2007 to Jun 30, 2007).	Disclosed in part	62
A-2011-00440	A listing of the Access to Information requests submitted to Health Canada for the period of December 2006.	All disclosed	4
A-2011-00441	A listing of the Access to Information requests submitted to Health Canada. (Jan 1, 2005 to May 31, 2005).	Disclosed in part	41
A-2011-00442	AER for the product Meridia. Report number: 000347653.	Disclosed in part	1
A-2011-00443	A listing of the Access to Information requests submitted to Health Canada. (Jan 1, 2004 to Dec 31, 2004).	Disclosed in part	73
A-2011-00444	A listing of the Access to Information requests submitted to Health Canada. (Jan 1, 2003 to Dec 31, 2003).	Disclosed in part	81
A-2011-00445	A listing of the Access to Information requests submitted to Health Canada. (Jan 1, 2002 to Dec 31, 2002).	Disclosed in part	62
A-2011-00446	A listing of the Access to Information requests submitted to Health Canada. (Jan 1, 2001 to Dec 31, 2001).	Disclosed in part	90
A-2011-00447	A listing of the Access to Information requests submitted to Health Canada. (Jan 1, 2000 to Dec 31, 2000).	Disclosed in part	70
A-2011-00448	A listing of the Access to Information requests submitted to Health Canada. (Jan 1, 1999 to Dec 31, 1999).	Disclosed in part	69
A-2011-00449	A listing of the Access to Information requests submitted to Health Canada. (Jan 1, 1997 to Dec 31, 1997).	Disclosed in part	55
A-2011-00451	A listing of the Access to Information requests submitted to Health Canada. (Jan 1, 1996 to Dec 31, 1996).	Disclosed in part	46
A-2011-00452	A listing of the Access to Information requests submitted to Health Canada. (Jan 1, 1995 to Dec 31, 1995).	Disclosed in part	43
A-2011-00453	A listing of the Access to Information requests submitted to Health Canada. (Jan 1, 1994 to Dec 31, 1994).	Disclosed in part	36
A-2011-00454	A listing of the Access to Information requests submitted to Health Canada. (Jan 1, 1993 to Dec 31, 1993).	Disclosed in part	31
A-2011-00455	A listing of the Access to Information requests submitted to Health Canada. (Jan 1, 1992 to Dec 31, 1992).	Disclosed in part	36
A-2011-00456	A listing of the Access to Information requests submitted to Health Canada. (Jan 1, 1991 to Dec 31, 1991).	Disclosed in part	30
A-2011-00457	A listing of the Access to Information requests submitted to Health Canada. (Jan 1, 1998 to Dec 31, 1998).	Disclosed in part	49
A-2011-00460	AER for the product Synagis. Report number: 000358717.	Disclosed in part	1
A-2011-00462	List of the 50 drugs most frequently requested and approved for supply under the Special Access Programme in 2010.	All disclosed	2
A-2011-00463	All documents which makes direct or indirect comparison to amlodipine besylate pursuant to the Regulations regarding alternate forms including salt forms such as amlodipine mesylate, other reference comparators to amlodipine besylate, or documents regarding therapeutic equivalence.	Disclosed in part	816
A-2011-00467	All local purchase orders processed by this institution in the National Capital Region for the procurement of Temporary Help Services during the period of June 2011.	All disclosed	1
A-2011-00468	Documentation which indicates all appointments term and casual employees by this institution in the National Capital Region under the term of the Public Service Employment Act during June 2011.	All disclosed	4
A-2011-00469	All callups and amendments issued under the terms of the TBIPS Standing Offer (EN578-055605) in the National Capital Region during the month of June 2011.	No records exist	0
A-2011-00470	All callups processed by this institution in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of June 2011.	All disclosed	69
A-2011-00472	Organizational chart of the Natural Health Products Directorate.	All disclosed	23
A-2011-00479	Provide any documentation that identifies adaptation measures necessary to respond to the risk of climate change for their department, the projected costs of adaptation and steps taken to date (July 20, 2011).	No records exist	0
A-2011-00485	Information regarding the product B12 1000 MCG, NPN 80012952 by Corporation Jamieson Laboratories Ltd.	All disclosed	18
A-2011-00489	AER for the product Meridia. Report number: 000354894.	Disclosed in part	1
A-2011-00493	Most current Product Monograph for Heparin Leo, DINs 00727520, 00579718, 00453811 and 00453781by Leo Pharma Inc.	No records exist	0
A-2011-00499	AER for the product Ebixa. Report number: 000364631.	Disclosed in part	1
A-2011-00502	Copy of the prescribing information and clinical review notes for the product TEVA-HYDROCHLOROTHIAZIDE, DINs 00021474 and 00021482 by TEVA CANADA LIMITED.	No records exist	0
A-2011-00505	All Access to Information Request replies from July 1, 2010 to July 1, 2011 for the Brand name drug Zyban CA/I Bupropion Hydrochloride) DIN 02238441 by Valean Canada LP	No records exist	0
A-2011-00508	AER for the product TECTA (pantoprazole magnesium). Report number: 000353544.	Disclosed in part	1
A-2011-00509	Documents previously released for 30 Access to Information requests regarding Medical Marihuana.	Disclosed in part	2,531
A-2011-00513	AERs for the product Avelox. Report numbers: 000365819, 000365910, 000366712, 000366754, 000367132 and 000367776.	Disclosed in part	6
A-2011-00514	AER for the product Adalat XL. Report number: 000367256.	Disclosed in part	2
A-2011-00515	AER for the product Magnevist. Report number: 000366609.	Disclosed in part	1
A-2011-00516	AERs for the product Mirena. Report numbers: 000366898, 000367181 and 000367777.	Disclosed in part	3
A-2011-00517	AERs for the product Yasmin. Report numbers: 000365538, 000365698, 000366241, 000367018, 000367052 and 000367141.	Disclosed in part	7
A-2011-00518	AERs for the product Xarelto. Report numbers: 000365433 and 000367658.	Disclosed in part	5
A-2011-00519	AERs for the product Yaz. Report numbers: 000365809, 000365865, 000366016, 000366121, 000367028 and 000367479.	Disclosed in part	14
A-2011-00520	AER for the product Multaq (dronedarone). Report number: 000363806.	All disclosed	1
A-2011-00524	Information regarding the products Anapen and Anapen Jr.	Disclosed in part	93
A-2011-00525	Full copy of a trade complaint filed against Mocelle Edan Cosmetic Clinic with the Health Product & Food Branch Inspectorate of Health Canada. The complaint was made with regards to an advertisement for the product Cosmetic Botox (DIN 02243721).	Disclosed in part	1
A-2011-00542	A copy of the Miner Exposure Database, which contains basic personal information collected from the personnel files of all miners who worked at the Rio Algom and Denison Mines in Elliot Lake from the early 1950's to the mid-1980's.	No records exist	0
A-2011-00555	Previously released requests A-2006-01159, A-2007-01054 and A-2008-00509: Regarding the product Salvia Divinorum.	Disclosed in part	391
A-2011-00557	Update Canada, authored and/or presented by Jocelyn Kula & Salvia: The Canadian Experience, authored and/or presented by Suzanne Desjardins during First international multidisciplinary forum on new drugs" in Lisbon on May 11-12, 2011.	All disclosed	24
A-2011-00558	All callups processed by this institution in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of July 2011.	Disclosed in part	42
A-2011-00559	All local purchase orders processed by this institution in the National Capital Region for the procurement of Temporary Help Services during the period of July 2011.	Disclosed in part	2
A-2011-00560	Documentation which indicates all appointments term and casual employees by this institution in the National Capital Region under the term of the Public Service Employment Act during July 2011.	All disclosed	4
A-2011-00561	All callups and amendments issued under the terms of the TBIPS Standing Offer (EN578-055605) in the National Capital Region during the month of July 2011.	No records exist	0
A-2011-00611	All submissions, emails, correspondence between Health Canada and researchers with the Royal Society of Canada related to the 2003 update called RECENT ADVANCES IN RESEARCH ON RADIOFREQUENCY FIELDS AND HEALTH: 2001-2003. (Jan 1, 2003 to Dec 31, 2003).	No records exist	0
A-2011-00615	The Canadian submissions to the International Narcotics Board to establish the 2011 status of estimates for narcotic drug use for Canada, including any relevant data concerning projected needs/usage for 2011.	Disclosed in part	16